Interestingly, the inhibition of CaMKII or of NFAT reduced stemness in GBM cell cultures [62,63,64], indicating that Ca2+ signaling plays a key role in maintaining or expanding the subpopulation of tumor-initiating cells responsible for GBM relapse. Here, CAMK2G is linked to glioblastoma.